Regenxbio Total Other Income Expense Net from 2010 to 2025

RGNX Stock  USD 7.37  0.22  3.08%   
Regenxbio Total Other Income Expense Net yearly trend continues to be fairly stable with very little volatility. Total Other Income Expense Net will likely drop to about 3.3 M in 2025. During the period from 2010 to 2025, Regenxbio Total Other Income Expense Net regression line of annual values had significance of  0.89 and arithmetic mean of  3,261,303. View All Fundamentals
 
Total Other Income Expense Net  
First Reported
2013-12-31
Previous Quarter
M
Current Value
2.5 M
Quarterly Volatility
6.2 M
 
Yuan Drop
 
Covid
Check Regenxbio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Regenxbio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 20.9 M, Interest Expense of 7.5 M or Selling General Administrative of 106.9 M, as well as many indicators such as Price To Sales Ratio of 9.5, Dividend Yield of 0.0 or PTB Ratio of 2.38. Regenxbio financial statements analysis is a perfect complement when working with Regenxbio Valuation or Volatility modules.
  
Check out the analysis of Regenxbio Correlation against competitors.
For more information on how to buy Regenxbio Stock please use our How to Invest in Regenxbio guide.

Latest Regenxbio's Total Other Income Expense Net Growth Pattern

Below is the plot of the Total Other Income Expense Net of Regenxbio over the last few years. It is Regenxbio's Total Other Income Expense Net historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Regenxbio's overall financial position and show how it may be relating to other accounts over time.
Total Other Income Expense Net10 Years Trend
Very volatile
   Total Other Income Expense Net   
       Timeline  

Regenxbio Total Other Income Expense Net Regression Statistics

Arithmetic Mean3,261,303
Coefficient Of Variation463.29
Mean Deviation8,002,254
Median1,938,000
Standard Deviation15,109,329
Sample Variance228.3T
Range70.2M
R-Value0.04
Mean Square Error244.3T
R-Squared0
Significance0.89
Slope118,349
Total Sum of Squares3424.4T

Regenxbio Total Other Income Expense Net History

20253.3 M
2024M
20234.5 M
2022-17.5 M
2021-18.7 M
202013.2 M
201951.5 M

About Regenxbio Financial Statements

Regenxbio investors use historical fundamental indicators, such as Regenxbio's Total Other Income Expense Net, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Regenxbio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Other Income Expense NetM3.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Regenxbio Stock Analysis

When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.